BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15765445)

  • 21. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
    Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
    Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal serrated adenocarcinoma.
    Mäkinen MJ
    Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma.
    Siraj AK; Bu R; Prabhakaran S; Bavi P; Beg S; Al Hazmi M; Al-Rasheed M; Alobaisi K; Al-Dayel F; AlManea H; Al-Sanea N; Uddin S; Al-Kuraya KS
    Mol Cancer; 2014 Jul; 13():168. PubMed ID: 25005754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients.
    Rasuck CG; Leite SM; Komatsuzaki F; Ferreira AC; Oliveira VC; Gomes KB
    Mol Biol Rep; 2012 Mar; 39(3):2553-60. PubMed ID: 21681432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
    Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
    Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
    Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
    Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability.
    Yamamoto H; Min Y; Itoh F; Imsumran A; Horiuchi S; Yoshida M; Iku S; Fukushima H; Imai K
    Genes Chromosomes Cancer; 2002 Mar; 33(3):322-5. PubMed ID: 11807990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
    Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
    Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
    Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
    Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.
    de Jong AE; van Puijenbroek M; Hendriks Y; Tops C; Wijnen J; Ausems MG; Meijers-Heijboer H; Wagner A; van Os TA; Bröcker-Vriends AH; Vasen HF; Morreau H
    Clin Cancer Res; 2004 Feb; 10(3):972-80. PubMed ID: 14871975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.
    Vasen HF; Hendriks Y; de Jong AE; van Puijenbroek M; Tops C; Bröcker-Vriends AH; Wijnen JT; Morreau H
    Dis Markers; 2004; 20(4-5):207-13. PubMed ID: 15528786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population.
    Rovella V; Carrara S; Crucitti SC; Coco C; Magistrelli P; Lucci-Cordisco E; Anti M; Neri G; Genuardi M
    Ann Oncol; 2001 Jun; 12(6):813-8. PubMed ID: 11484957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtypes of colorectal cancers determined by PCR-based analysis.
    Sugai T; Eizuka M; Takahashi Y; Fukagawa T; Habano W; Yamamoto E; Akasaka R; Otuska K; Matsumoto T; Suzuki H
    Cancer Sci; 2017 Mar; 108(3):427-434. PubMed ID: 28083970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.